chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Nausea
Clinical narrative: Dizzy; Weak after the 2nd dose; Nausea that is slowly getting stronger and stronger after the 2nd dose / Nauseated upon standing after the 2nd dose / Nauseated after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), ASTHENIA (Weak after the 2nd dose) and NAUSEA (Nausea that is slowly getting stronger and stronger after the 2nd dose / Nauseated upon standing after the 2nd dose / Nauseated after the 2nd dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026a21a and 021b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy), ASTHENIA (Weak after the 2nd dose) and NAUSEA (Nausea that is slowly getting stronger and stronger after the 2nd dose / Nauseated upon standing after the 2nd dose / Nauseated after the 2nd dose). At the time of the report, DIZZINESS (Dizzy), ASTHENIA (Weak after the 2nd dose) and NAUSEA (Nausea that is slowly getting stronger and stronger after the 2nd dose / Nauseated upon standing after the 2nd dose / Nauseated after the 2nd dose) outcome was unknown. Not Provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Heart rate increased, Lymphadenopathy, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), HEART RATE INCREASED (Rapid heart beat which happens when I get a cold), FATIGUE (Fatigue), LYMPHADENOPATHY (Swollen lymph nodes in underarm on left side) and PYREXIA (Fever for second and third day after vaccine) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.  Concomitant products included DILTIAZEM and PRAVASTATIN for an unknown indication. On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced ASTHENIA (Weakness) and FATIGUE (Fatigue). On 08-May-2021, the patient experienced HEART RATE INCREASED (Rapid heart beat which happens when I get a cold) and PYREXIA (Fever for second and third day after vaccine). On 09-May-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in underarm on left side). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 09-May-2021, ASTHENIA (Weakness), HEART RATE INCREASED (Rapid heart beat which happens when I get a cold), FATIGUE (Fatigue) and PYREXIA (Fever for second and third day after vaccine) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes in underarm on left side) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: Vaccine which were kept above -80C for 5 minutes and noticed that 2 doses were given to two patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine which were kept above -80C for 5 minutes and noticed that 2 doses were given to two patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine which were kept above -80C for 5 minutes and noticed that 2 doses were given to two patients). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine which were kept above -80C for 5 minutes and noticed that 2 doses were given to two patients) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Reporter said these patients are part of Research and their identification is unknown.  No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: excruciating pain in the legs; fatigued; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (excruciating pain in the legs) and FATIGUE (fatigued) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CLOPIDOGREL for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (excruciating pain in the legs) and FATIGUE (fatigued). At the time of the report, PAIN IN EXTREMITY (excruciating pain in the legs) and FATIGUE (fatigued) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   This case was linked to MOD-2021-116655 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Deviation from the recommended interval between the two doses) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.No concomitant medication was reported    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Deviation from the recommended interval between the two doses). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Deviation from the recommended interval between the two doses) outcome was unknown. Not Provided    Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I received my first shot around one month ago (4-6 weeks ago). If i don't get it right away will the first shot be invalid; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I received my first shot around one month ago (4-6 weeks ago). If i don't get it right away will the first shot be invalid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Diabetes medication and High blood pressure medication for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I received my first shot around one month ago (4-6 weeks ago). If i don't get it right away will the first shot be invalid).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Dizziness, Pain, Pain in extremity
Clinical narrative: feeling light headed; arm is  swollen; cannot touch her armpit; it hurts to use her arm; arm is sore; armpit is sore; pain in her shoulder and down her arm,; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling light headed), PERIPHERAL SWELLING (arm is  swollen), PAIN (cannot touch her armpit), PAIN (it hurts to use her arm) and PAIN IN EXTREMITY (arm is sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (feeling light headed), PERIPHERAL SWELLING (arm is  swollen), PAIN (cannot touch her armpit), PAIN (it hurts to use her arm), PAIN IN EXTREMITY (arm is sore), AXILLARY PAIN (armpit is sore) and ARTHRALGIA (pain in her shoulder and down her arm,). At the time of the report, DIZZINESS (feeling light headed), PERIPHERAL SWELLING (arm is  swollen), PAIN (cannot touch her armpit), PAIN (it hurts to use her arm), PAIN IN EXTREMITY (arm is sore), AXILLARY PAIN (armpit is sore) and ARTHRALGIA (pain in her shoulder and down her arm,) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medicines were not provided Action taken with mRNA-1273 in response to the event was unknown
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: feeling light headed; arm is  swollen; cannot touch her armpit; it hurts to use her arm; arm is sore; armpit is sore; pain in her shoulder and down her arm,; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling light headed), PERIPHERAL SWELLING (arm is  swollen), PAIN (cannot touch her armpit), PAIN (it hurts to use her arm) and PAIN IN EXTREMITY (arm is sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (feeling light headed), PERIPHERAL SWELLING (arm is  swollen), PAIN (cannot touch her armpit), PAIN (it hurts to use her arm), PAIN IN EXTREMITY (arm is sore), AXILLARY PAIN (armpit is sore) and ARTHRALGIA (pain in her shoulder and down her arm,). At the time of the report, DIZZINESS (feeling light headed), PERIPHERAL SWELLING (arm is  swollen), PAIN (cannot touch her armpit), PAIN (it hurts to use her arm), PAIN IN EXTREMITY (arm is sore), AXILLARY PAIN (armpit is sore) and ARTHRALGIA (pain in her shoulder and down her arm,) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medicines were not provided Action taken with mRNA-1273 in response to the event was unknown
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Hyperhidrosis, Myalgia
Clinical narrative: Worse brain fog; Fatigue,tired; Muscle aches; Nausea; Chills; Sweats; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (Sweats), FEELING ABNORMAL (Worse brain fog), FATIGUE (Fatigue,tired), MYALGIA (Muscle aches) and NAUSEA (Nausea) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypotension, Arrhythmia and Fatigue. Concurrent medical conditions included Chronic fatigue syndrome, Fibromyalgia and Neurocardiogenic syncope.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HYPERHIDROSIS (Sweats), FATIGUE (Fatigue,tired), MYALGIA (Muscle aches), NAUSEA (Nausea) and CHILLS (Chills). On 17-Jan-2021, the patient experienced FEELING ABNORMAL (Worse brain fog). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 17-Jan-2021, HYPERHIDROSIS (Sweats), FATIGUE (Fatigue,tired), MYALGIA (Muscle aches), NAUSEA (Nausea) and CHILLS (Chills) had resolved. On 27-Jan-2021, FEELING ABNORMAL (Worse brain fog) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator     This case was linked to MOD-2021-116657 (Patient Link).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Worse brain fog; Fatigue,tired; Muscle aches; Nausea; Chills; Sweats; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (Sweats), FEELING ABNORMAL (Worse brain fog), FATIGUE (Fatigue,tired), MYALGIA (Muscle aches) and NAUSEA (Nausea) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypotension, Arrhythmia and Fatigue. Concurrent medical conditions included Chronic fatigue syndrome, Fibromyalgia and Neurocardiogenic syncope.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HYPERHIDROSIS (Sweats), FATIGUE (Fatigue,tired), MYALGIA (Muscle aches), NAUSEA (Nausea) and CHILLS (Chills). On 17-Jan-2021, the patient experienced FEELING ABNORMAL (Worse brain fog). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 17-Jan-2021, HYPERHIDROSIS (Sweats), FATIGUE (Fatigue,tired), MYALGIA (Muscle aches), NAUSEA (Nausea) and CHILLS (Chills) had resolved. On 27-Jan-2021, FEELING ABNORMAL (Worse brain fog) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator     This case was linked to MOD-2021-116657 (Patient Link).
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included COLECALCIFEROL (VITAMIN D 3) and NAPROXEN (MOTRIN [NAPROXEN]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced RASH (rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs). At the time of the report, RASH (rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient was reported to receive treatment for the symptoms developed. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-055550 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash macular
Clinical narrative: having red splotch appear like a raised pancake on the skin; splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black; This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (having red splotch appear like a raised pancake on the skin) and INJECTION SITE RASH (splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     The patient's past medical history included Lyme's disease in 2009 and Spider bite ((~3-4 years ago)). Concomitant products included ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), MELALEUCA VIRIDIFLORA ESSENTIAL OIL, FISH OIL and LINUM USITATISSIMUM OIL (FLAXSEED OIL [LINUM USITATISSIMUM OIL]) for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced RASH MACULAR (having red splotch appear like a raised pancake on the skin) and INJECTION SITE RASH (splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black). At the time of the report, RASH MACULAR (having red splotch appear like a raised pancake on the skin) and INJECTION SITE RASH (splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Areds green, Areds yellow.  Treatment information was not provided.   Reporter did not allow further contact
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Headache, Intermenstrual bleeding, Pain in extremity
Clinical narrative: light spotting; Slight headache; sore right arm; Had no had menstrual cycle since receiving 1st and 2nd doses.; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (Had no had menstrual cycle since receiving 1st and 2nd doses.), PAIN IN EXTREMITY (sore right arm), INTERMENSTRUAL BLEEDING (light spotting) and HEADACHE (Slight headache) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced AMENORRHOEA (Had no had menstrual cycle since receiving 1st and 2nd doses.). On 09-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (sore right arm) and HEADACHE (Slight headache). On 08-May-2021, the patient experienced INTERMENSTRUAL BLEEDING (light spotting). On 11-Apr-2021, PAIN IN EXTREMITY (sore right arm) and HEADACHE (Slight headache) had resolved. On 09-May-2021, INTERMENSTRUAL BLEEDING (light spotting) had resolved. At the time of the report, AMENORRHOEA (Had no had menstrual cycle since receiving 1st and 2nd doses.) had not resolved. Not Provided          No Concomitant medications were reported.  No treatment details were reported.   This case was linked to MOD-2021-116659 (Patient Link).
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Hyperhidrosis
Clinical narrative: Sore throat; Sweating; Felt sick; Head rash; Headache; Swelling lymph node; Chills; Fatigue; Throw up; Foggy brain; Felt sick; Bad headache; Chills; Fever; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Foggy brain), the first episode of ILLNESS (Felt sick), OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating) and the second episode of ILLNESS (Felt sick) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced FEELING ABNORMAL (Foggy brain), the first episode of ILLNESS (Felt sick), HEADACHE (Bad headache), the first episode of CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), the first episode of FATIGUE (Fatigue) and VOMITING (Throw up). On 07-May-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating), the second episode of ILLNESS (Felt sick), RASH (Head rash), HEADACHE (Headache), LYMPHADENOPATHY (Swelling lymph node), the second episode of CHILLS (Chills) and the second episode of FATIGUE (Fatigue). On 28-Apr-2021, FEELING ABNORMAL (Foggy brain), HEADACHE (Bad headache), PYREXIA (Fever), NAUSEA (Nausea) and VOMITING (Throw up) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating), the last episode of ILLNESS (Felt sick), RASH (Head rash), HEADACHE (Headache), LYMPHADENOPATHY (Swelling lymph node), the last episode of CHILLS (Chills) and the last episode of FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use of birth control pills was reported  Treatment using advil(Ibuprofen) was reported
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Lymphadenopathy, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; Sweating; Felt sick; Head rash; Headache; Swelling lymph node; Chills; Fatigue; Throw up; Foggy brain; Felt sick; Bad headache; Chills; Fever; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Foggy brain), the first episode of ILLNESS (Felt sick), OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating) and the second episode of ILLNESS (Felt sick) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced FEELING ABNORMAL (Foggy brain), the first episode of ILLNESS (Felt sick), HEADACHE (Bad headache), the first episode of CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), the first episode of FATIGUE (Fatigue) and VOMITING (Throw up). On 07-May-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating), the second episode of ILLNESS (Felt sick), RASH (Head rash), HEADACHE (Headache), LYMPHADENOPATHY (Swelling lymph node), the second episode of CHILLS (Chills) and the second episode of FATIGUE (Fatigue). On 28-Apr-2021, FEELING ABNORMAL (Foggy brain), HEADACHE (Bad headache), PYREXIA (Fever), NAUSEA (Nausea) and VOMITING (Throw up) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating), the last episode of ILLNESS (Felt sick), RASH (Head rash), HEADACHE (Headache), LYMPHADENOPATHY (Swelling lymph node), the last episode of CHILLS (Chills) and the last episode of FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use of birth control pills was reported  Treatment using advil(Ibuprofen) was reported
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: Sore throat; Sweating; Felt sick; Head rash; Headache; Swelling lymph node; Chills; Fatigue; Throw up; Foggy brain; Felt sick; Bad headache; Chills; Fever; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Foggy brain), the first episode of ILLNESS (Felt sick), OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating) and the second episode of ILLNESS (Felt sick) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced FEELING ABNORMAL (Foggy brain), the first episode of ILLNESS (Felt sick), HEADACHE (Bad headache), the first episode of CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), the first episode of FATIGUE (Fatigue) and VOMITING (Throw up). On 07-May-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating), the second episode of ILLNESS (Felt sick), RASH (Head rash), HEADACHE (Headache), LYMPHADENOPATHY (Swelling lymph node), the second episode of CHILLS (Chills) and the second episode of FATIGUE (Fatigue). On 28-Apr-2021, FEELING ABNORMAL (Foggy brain), HEADACHE (Bad headache), PYREXIA (Fever), NAUSEA (Nausea) and VOMITING (Throw up) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), HYPERHIDROSIS (Sweating), the last episode of ILLNESS (Felt sick), RASH (Head rash), HEADACHE (Headache), LYMPHADENOPATHY (Swelling lymph node), the last episode of CHILLS (Chills) and the last episode of FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use of birth control pills was reported  Treatment using advil(Ibuprofen) was reported
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Sinus congestion, Somnolence
Clinical narrative: Sinuses stuffed up; Sleepy/sleeping more around 12hr; Kind of weak; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SINUS CONGESTION (Sinuses stuffed up), SOMNOLENCE (Sleepy/sleeping more around 12hr), ASTHENIA (Kind of weak) and FATIGUE (Exhausted) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced SINUS CONGESTION (Sinuses stuffed up), SOMNOLENCE (Sleepy/sleeping more around 12hr), ASTHENIA (Kind of weak) and FATIGUE (Exhausted). At the time of the report, SINUS CONGESTION (Sinuses stuffed up) was resolving and SOMNOLENCE (Sleepy/sleeping more around 12hr), ASTHENIA (Kind of weak) and FATIGUE (Exhausted) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore injection site; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Sore injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore injection site). At the time of the report, VACCINATION SITE PAIN (Sore injection site) outcome was unknown. Not Provided          Treatment information not provided. Concomitant medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-116661, US-MODERNATX, INC.-MOD-2021-116616, US-MODERNATX, INC.-MOD-2021-116619 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116661:Case for second dose US-MODERNATX, INC.-MOD-2021-116616:Case for daughter US-MODERNATX, INC.-MOD-2021-116619:Cluster case for other people having spinal pain
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Decreased appetite, Pain in extremity
Clinical narrative: Had no had menstrual cycle since receiving 1st doses; sore left arm; did not eat for two days "I do not know if it is because it was the weekend and I was busy or if it; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (Had no had menstrual cycle since receiving 1st doses), PAIN IN EXTREMITY (sore left arm) and DECREASED APPETITE (did not eat for two days "I do not know if it is because it was the weekend and I was busy or if it) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced AMENORRHOEA (Had no had menstrual cycle since receiving 1st doses), PAIN IN EXTREMITY (sore left arm) and DECREASED APPETITE (did not eat for two days "I do not know if it is because it was the weekend and I was busy or if it). On 14-Mar-2021, PAIN IN EXTREMITY (sore left arm) and DECREASED APPETITE (did not eat for two days "I do not know if it is because it was the weekend and I was busy or if it) had resolved. At the time of the report, AMENORRHOEA (Had no had menstrual cycle since receiving 1st doses) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. Treatment information was not provided.    This case was linked to MOD-2021-116650 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: Her arm was stiff; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Her arm was stiff) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Her arm was stiff). At the time of the report, MUSCULOSKELETAL STIFFNESS (Her arm was stiff) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment drugs were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-116546 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116546:Reporter's mother case
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Spinal pain
Clinical narrative: Length of my spine aches; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SPINAL PAIN (Length of my spine aches) and HEADACHE (Headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced SPINAL PAIN (Length of my spine aches) and HEADACHE (Headache). At the time of the report, SPINAL PAIN (Length of my spine aches) had not resolved and HEADACHE (Headache) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment of the events include acetaminophen. Patient was going to consult a spine specialist on 19 May 2021.   This case was linked to US-MODERNATX, INC.-MOD-2021-116654, US-MODERNATX, INC.-MOD-2021-116616, US-MODERNATX, INC.-MOD-2021-116619 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116654:Case for first dose US-MODERNATX, INC.-MOD-2021-116616:case daughter US-MODERNATX, INC.-MOD-2021-116619:Cluster case for other people having spinal pain
Age: 38.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Joint warmth, Muscle spasms, Musculoskeletal stiffness, Neck pain
Clinical narrative: arm soreness; felt hot; I work in construction my next is always sore. The area above collarbone was swollen.; The area above collarbone was swollen; cramping on the left side near the ribcage in the front and back; tightness in my neck; something rubbing against my collarbone; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm soreness), JOINT WARMTH (felt hot), NECK PAIN (I work in construction my next is always sore. The area above collarbone was swollen.), SWELLING (The area above collarbone was swollen) and MUSCLE SPASMS (cramping on the left side near the ribcage in the front and back) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), JOINT WARMTH (felt hot), NECK PAIN (I work in construction my next is always sore. The area above collarbone was swollen.), SWELLING (The area above collarbone was swollen), MUSCLE SPASMS (cramping on the left side near the ribcage in the front and back), MUSCULOSKELETAL STIFFNESS (tightness in my neck) and ARTHRALGIA (something rubbing against my collarbone). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness), JOINT WARMTH (felt hot), NECK PAIN (I work in construction my next is always sore. The area above collarbone was swollen.), SWELLING (The area above collarbone was swollen), MUSCLE SPASMS (cramping on the left side near the ribcage in the front and back), MUSCULOSKELETAL STIFFNESS (tightness in my neck) and ARTHRALGIA (something rubbing against my collarbone) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) SARS-CoV-2 test-positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 38.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test, Swelling
Clinical narrative: arm soreness; felt hot; I work in construction my next is always sore. The area above collarbone was swollen.; The area above collarbone was swollen; cramping on the left side near the ribcage in the front and back; tightness in my neck; something rubbing against my collarbone; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm soreness), JOINT WARMTH (felt hot), NECK PAIN (I work in construction my next is always sore. The area above collarbone was swollen.), SWELLING (The area above collarbone was swollen) and MUSCLE SPASMS (cramping on the left side near the ribcage in the front and back) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), JOINT WARMTH (felt hot), NECK PAIN (I work in construction my next is always sore. The area above collarbone was swollen.), SWELLING (The area above collarbone was swollen), MUSCLE SPASMS (cramping on the left side near the ribcage in the front and back), MUSCULOSKELETAL STIFFNESS (tightness in my neck) and ARTHRALGIA (something rubbing against my collarbone). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness), JOINT WARMTH (felt hot), NECK PAIN (I work in construction my next is always sore. The area above collarbone was swollen.), SWELLING (The area above collarbone was swollen), MUSCLE SPASMS (cramping on the left side near the ribcage in the front and back), MUSCULOSKELETAL STIFFNESS (tightness in my neck) and ARTHRALGIA (something rubbing against my collarbone) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) SARS-CoV-2 test-positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm at the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm at the injection). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeling cold, Hyperhidrosis
Clinical narrative: sensitivity to cold; dizziness; sweats; severe chills; fatigue; muscle pain in his arm and throughout his body; low grade fever; a little tired; arm was slightly sore; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (sensitivity to cold), DIZZINESS (dizziness), HYPERHIDROSIS (sweats), PAIN IN EXTREMITY (arm was slightly sore) and CHILLS (severe chills) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was slightly sore) and FATIGUE (a little tired). On 18-Feb-2021, the patient experienced DIZZINESS (dizziness), HYPERHIDROSIS (sweats), CHILLS (severe chills), FATIGUE (fatigue), MYALGIA (muscle pain in his arm and throughout his body) and PYREXIA (low grade fever). On 22-Feb-2021, the patient experienced FEELING COLD (sensitivity to cold). On 11-Feb-2021, PAIN IN EXTREMITY (arm was slightly sore) and FATIGUE (a little tired) had resolved. On 18-Feb-2021, FATIGUE (fatigue) had resolved. On 22-Feb-2021, DIZZINESS (dizziness), HYPERHIDROSIS (sweats), CHILLS (severe chills), MYALGIA (muscle pain in his arm and throughout his body) and PYREXIA (low grade fever) had resolved. At the time of the report, FEELING COLD (sensitivity to cold) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported. Treatment information included Aleve.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: sensitivity to cold; dizziness; sweats; severe chills; fatigue; muscle pain in his arm and throughout his body; low grade fever; a little tired; arm was slightly sore; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (sensitivity to cold), DIZZINESS (dizziness), HYPERHIDROSIS (sweats), PAIN IN EXTREMITY (arm was slightly sore) and CHILLS (severe chills) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was slightly sore) and FATIGUE (a little tired). On 18-Feb-2021, the patient experienced DIZZINESS (dizziness), HYPERHIDROSIS (sweats), CHILLS (severe chills), FATIGUE (fatigue), MYALGIA (muscle pain in his arm and throughout his body) and PYREXIA (low grade fever). On 22-Feb-2021, the patient experienced FEELING COLD (sensitivity to cold). On 11-Feb-2021, PAIN IN EXTREMITY (arm was slightly sore) and FATIGUE (a little tired) had resolved. On 18-Feb-2021, FATIGUE (fatigue) had resolved. On 22-Feb-2021, DIZZINESS (dizziness), HYPERHIDROSIS (sweats), CHILLS (severe chills), MYALGIA (muscle pain in his arm and throughout his body) and PYREXIA (low grade fever) had resolved. At the time of the report, FEELING COLD (sensitivity to cold) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported. Treatment information included Aleve.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Urticaria
Clinical narrative: Hives; Numbness and tingling; This spontaneous case was reported by a health care professional and describes the occurrence of URTICARIA (Hives) and HYPOAESTHESIA (Numbness and tingling) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives) and HYPOAESTHESIA (Numbness and tingling). At the time of the report, URTICARIA (Hives) and HYPOAESTHESIA (Numbness and tingling) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-049553 (E2B Linked Report).; Sender's Comments:  MOD21-049553:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Minimal Side Effects After First Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Minimal Side Effects After First Vaccine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION COMPLICATION (Minimal Side Effects After First Vaccine). On 16-Mar-2021, VACCINATION COMPLICATION (Minimal Side Effects After First Vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications as not reported by reporter  Treatment medications were not provided   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-116676 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116676: